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     UNIT 2.6Deoxyribo- and Ribonucleoside
H-Phosphonates
This unit includes a collection of four synthetic methods for nucleoside H-phosphonate
building blocks and a variant on one of these syntheses. All the methods are quite efficient
and experimentally simple, and they use readily available reagents. Depending on
reactivity and reaction conditions, different methods may be preferred for preparation of
different building blocks.
The phosphonylation of protected nucleosides with the in situ–generated tris-(1-imida-
zolyl)phosphine (from phosphorus trichloride and imidazole), followed by hydrolysis of
the formed nucleoside diimidazolyl phosphite intermediate, is described in Basic Protocol
1. This method (or its variants with other azoles) is probably the most widely used and
can be recommended as a general basic method applicable for the preparation of both
deoxyribo- and ribonucleoside 3′-H-phosphonates. Imidazole from the first published
procedure (Garegg et al., 1986c) is preferred over the other azoles (e.g., triazole; Froehler
et al., 1986) because it is less expensive and forms the least reactive species. Since
tris-(1-imidazolyl)phosphine is a trifunctional reagent, it should be used in excess in the
phosphonylation reaction to avoid the formation of symmetrical H-phosphonate diesters.
There are several variants of this protocol that differ in the kind of azoles, external bases,
or solvents used, including procedures for ribonucleoside building blocks that combine
2′-O-protection and 3′-O-phosphonylation. The Alternate Protocol describes one of these
procedures (also see Commentary).
In Basic Protocol 2, pyridinium H-pyrophosphonate, generated in situ from phosphorous
acid and a condensing agent, is used. This one-step reaction is most likely carried out by
a nucleophilic attack of nucleoside on a phosphorus center of H-pyrophosphonate.
Usually 5 mol eq in excess of the nucleoside is used to speed up the reaction. The chemical
nature of a condensing agent is of minor importance for the final yield of the H-phos-
phonate monoesters. Phosphonylation of ribonucleosides protected with 2′-O-tert-
butyldimethylsilyl (2′-O-TBDMS) occurs very slowly with this reagent, which makes it
less suitable for use in preparation of ribonucleoside building blocks.
Basic Protocol 3 describes a convenient approach for the preparation of nucleoside
H-phosphonate monoesters based on transesterification of diphenyl H-phosphonate with
protected nucleosides. Diphenyl H-phosphonate is relatively inexpensive, commercially
available, stable, and easy to handle. It also gives high yields of nucleoside H-phosphon-
ates. This is the newest of the presented methods and thus the least used, but some clear
advantages of the method could make it a generally preferred choice. It should, however,
be noted that synthesis of ribonucleoside building blocks with this method requires more
basic work-up conditions, which may prevent its use with N-protections that are quite
base labile.
Basic Protocol 4 makes use of 2-chloro-4H-1,3,2-benzo-dioxaphosphinan-4-one (salicyl-
chlorophosphite) as the phosphonylating reagent. The reaction with nucleosides is usually
fast and quantitatively produces a phosphite intermediate that is converted into the
H-phosphonate monoester upon hydrolysis. Since salicylchlorophosphite is practically a
monofunctional phosphonylating agent, it can be used in nearly stoichiometric amounts.
The formation of symmetrical dinucleoside H-phosphonate diesters is usually negligible,
but removal of byproducts from the reagent can sometimes be a problem.
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Synthesis
NOTE: These reactions should be carried out under strictly anhydrous conditions, using
anhydrous solvents and reagents. All glassware should be dried in an oven prior to use.
The nucleosidic component should be rendered anhydrous by consecutive evaporation of
added pyridine or acetonitrile depending on solvent used for the reaction. All connections
to atmospheric pressure should be through a drying tower containing a desiccant.
     BASIC     
PROTOCOL 1
SYNTHESIS OF PROTECTED DEOXYRIBONUCLEOSIDE OR
RIBONUCLEOSIDE 3′-H-PHOSPHONATES USING THE PHOSPHORUS
TRICHLORIDE/IMIDAZOLE/TRIETHYLAMINE REAGENT
This is a general-purpose protocol, applicable to both ribo- and deoxyribonucleosides
bearing standard protecting groups. This reaction is shown in Figure 2.6.1.
Materials
Imidazole, made anhydrous by repeated evaporation of added dry acetonitrile
Dichloromethane (99.9+%; HPLC grade), stored over 3A molecular sieves
Acetone (for dry ice/acetone bath)
Phosphorus trichloride, freshly distilled
Triethylamine, distilled, stored over calcium hydride
Protected deoxyribo- or ribonucleoside (see Chapter 2), dried by repeated
evaporation of added pyridine
9:1 (v/v) chloroform/methanol
2 M TEAB, pH 7.5 (see recipe)
Sodium sulfate
5 × 25–cm glass chromatography column, packed with Merck silica gel 60, 230 to
400 mesh ASTM (e.g., EM Science) or matrix silica, 35 to 70 µm (Millipore) in
chloroform (bed height, 15 to 20 cm)
Methanol
Chloroform
0.5:1:8.5 or 1:2:7 (v/v/v) concentrated ammonia/water/isopropanol
1:1 (v/v) hexane/diethyl ether
TLC silica-gel plates (e.g., Merck silica gel 60 F254, EM Science)
Rotary evaporator connected to water aspirator
Additional reagents and equipment for thin-layer chromatography (TLC; APPENDIX
3D) and column chromatography (APPENDIX 3E)
Figure 2.6.1 Synthesis of nucleoside 3′-H-phosphonates using PCl3/Im/TEA reagent system.
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Prepare phosphorus trichloride/imidazole/triethylamine reagent
1. Dissolve 5.8 g imidazole (86 mmol) in 300 mL dichloromethane and cool solution
to approximately −10°C in a dry ice/acetone bath.
Dry acetonitrile and tetrahydrofuran can be used as alternative solvents, but with dichlo-
romethane the work-up procedure is more convenient.
2. While stirring, add dropwise 2.45 mL phosphorus trichloride (28 mmol) and then
12.5 mL triethylamine (90 mmol) mixed with 10 mL dichloromethane. Stir 15 to 30
min at 0° to −10°C and then cool to −78°C in dry ice/acetone bath.
Prepare 3′-H-phosphonates
3. Add a protected deoxyribo- or ribonucleoside (8 mmol) dissolved in 200 mL
dichloromethane dropwise over ∼30 min while stirring at −78°C. Stir 1 hr at −78°C.
Steps 1 to 3 can be somewhat simplified by cooling the mixture with an ice/water bath
instead; however, this is not recommended for guanosine and deoxyguanosine derivatives
because substantial amounts of side products, and thus a lower yield, can be produced
following subsequent reactions (presumably with the lactam system).
4. Monitor reactions for disappearance of the starting nucleoside and the formation of
a baseline material by TLC (APPENDIX 3D) on silica-gel plates using 9:1 chloro-
form/methanol as the solvent.
5. When the reaction is complete (as determined by TLC analysis), pour the cold mixture
directly onto 300 mL of 2 M TEAB and wash the organic layer with an additional
300 mL of 2 M TEAB.
With acetonitrile as solvent, 20 mL of 0.5 M TEAB should be added to the cold mixture.
The mixture is then concentrated under reduced pressure (at 30° to 40°C) and the residue
is dissolved in 300 mL dichloromethane and washed twice with 150 mL of 2 M TEAB.
6. Separate the organic layer, dry it over ~20 g sodium sulfate, and evaporate solvent
under reduced pressure using a rotary evaporator connected to a water aspirator.
Purify 3′-H-phosphonates
7. Purify crude product by short-column silica-gel chromatography (APPENDIX 3E) on a
5 × 25–cm glass chromatography column using a stepwise gradient of  methanol in
chloroform to elute products.
For example, a stepwise gradient of 0% to 12% methanol in chloroform containing 0.1%
triethylamine can be used.
Unwanted isomers of the ribonucleoside H-phosphonates, that is 3′-TBDMS (or 2-ClBz)
2′-H-phosphonates, if present, are readily removed by silica-gel chromatography.
8. Check eluate fractions for H-phosphonate purity by TLC using 0.5:1:8.5 or 1:2:7
(v/v/v) concentrated ammonia/water/isopropanol as the solvent.
The polarity, and thus the mobility on TLC, of an H-phosphonate will be affected by its
protecting group. The latter solvent is probably better for more polar compounds.
For compounds bearing more base-labile N-protection, the use of 3:7 or 2:8 (v/v) iso-
propanol/1 M TEAB can be advantageous.
9. Combine fractions containing the desired product and concentrate them to a white
foam using the rotary evaporator. Store at <4°C.
A yield of 70% to 95% 3′-H-phosphonate monoesters (triethylammonium salts), based on
the staring quantity of nucleoside, is expected.
Current Protocols in Nucleic Acid Chemistry Supplement 4
2.6.3
Protection of
Nucleosides for
Oligonucleotide
Synthesis
Occasionally, DBUH+ salts of H-phosphonate monoesters can be preferred to TEAH+ salts.
The transformation can be effected by washing a solution of nucleoside H-phosphonate
monoester (triethylammonium salt) in dichloromethane with 0.2 M 1,8-diazabicy-
clo[5.4.0]undec-7-ene (DBU) bicarbonate buffer (pH 8.5).
10. Optional: Dissolve foam in a small amount of dichloromethane and add it dropwise
while stirring vigorously to 100 to 150 mL of 1:1 hexane/diethyl ether per mmol
product. Store at <4°C.
The nucleoside H-phosphonate is stored as a microcrystalline solid. Although stable for
several months at room temperature, it should be stored in the freezer to prevent decom-
position due to residual solvents. Under such conditions, no decomposition is seen even
after several months.
ALTERNATE
 PROTOCOL
SYNTHESIS OF RIBONUCLEOSIDE 3′-H-PHOSPHONATES VIA IN SITU
2′-O-2-CHLOROBENZOYLATION FOLLOWED BY PHOSPHONYLATION
This procedure is specific for ribonucleosides bearing a 2′-O-chlorobenzoyl group and
permits simultaneous 2′-O-benzoylation and 3′-O-H-phosphorylation as a “one pot”
reaction.
Additional Materials (also see Basic Protocol 1)
Protected ribonucleoside with free 2′- and 3′-hydroxyls (see Chapter 2), dried by
repeated evaporation of added pyridine
Pyridine (HPLC grade; e.g., LabScan), dried by and stored over 4A molecular
sieves
2-Chlorobenzoyl chloride
1. Dissolve a protected ribonucleoside with free 2′- and 3′-hydroxyls (8 mmol) in 95
mL dichloromethane and add 5 mL pyridine. Cool to −78°C in a dry ice/acetone bath
while stirring.
2. Mix 1.18 mL 2-chlorobenzoyl chloride (8.8 mmol) and 10 mL dichloromethane, and
add dropwise over a 15-min period. Incubate 30 min at −78°C with stirring.
3. Prepare phosphorus trichloride/imidazole/triethylamine reagent as described (see
Basic Protocol 1, steps 1 and 2).
4. Add phosphorus trichloride/imidazole/triethylamine reagent dropwise over 15 to 30
min to nucleoside mixture while stirring at −78°C. Stir 1 hr at −78°C.
5. Continue with synthesis and purification as described (see Basic Protocol 1, steps 4
to 10).
A yield of 40% to 70%, based on the starting quantity of nucleoside, is expected.
     BASIC     
PROTOCOL 2
SYNTHESIS OF PROTECTED DEOXYRIBONUCLEOSIDE
3′-H-PHOSPHONATES USING H-PYROPHOSPHONATE
This procedure is suitable for phosphorylation of hydroxyl groups in deoxyribonu-
cleosides or 5′-hydroxyl groups in ribonucleosides. This reaction is shown in Figure 2.6.2.
Materials
Protected deoxyribonucleoside (see Chapter 2), dried by repeated evaporation of
added pyridine
2 M phosphorous acid (H3PO3) solution (see recipe)
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Condensing agent (select one):
 5,5-Dimethyl-2-oxo-2-chloro-1,3,2-dioxaphosphinane (NEPCl; see recipe)
 Pivaloyl chloride (PV⋅Cl), commercial grade (e.g., Aldrich), distilled before use
(store <2 months at −20°C)
9:1 (v/v) chloroform/methanol
1 M and 2 M TEAB, pH 7.5 (see recipe)
Dichloromethane (HPLC grade), stored over 3A molecular sieves
Sodium sulfate
4 × 25–cm glass chromatography column, packed with Merck silica gel 60, 230 to
400 mesh ASTM (e.g., EM Science) or Matrix silica, 35 to 70 µm (Millipore) in
chloroform (bed height, 10 to 15 cm)
Methanol
Chloroform
0.5:1:8.5 or 1:2:7 (v/v/v) concentrated ammonia/water/isopropanol
1:1 (v/v) hexane/diethyl ether
TLC silica-gel plates (e.g., Merck silica gel 60 F254, EM Science)
Rotary evaporator connected to water aspirator
Additional reagents and equipment for TLC (APPENDIX 3D) and column
chromatography (APPENDIX 3E)
1. Dissolve protected deoxyribonucleoside (2 mmol) in 10 mL of 2 M H3PO3 solution
(20 mmol).
2. Stir reaction mixture and slowly add 2.0 g NEPCl (11 mmol) or 1.35 mL PV⋅Cl (11
mmol). Stir ∼3 hr.
The reaction can be left overnight at 20°C (room temperature). 
The specified amount of a condensing agent should not be exceeded, otherwise more
reactive species can be generated from phosphorous acid, which may result in a significant
formation of symmetrical H-phosphonate diesters.
Instead of generating H-pyrophosphonate in situ from phosphorous acid and a condensing
agent, a 1 M stock solution of this phosphonylating reagent can be prepared by adding 0.5
mol eq PV⋅Cl or NEPCl to 2 M H3PO3 in pyridine. The stock solution of pyridinium
H-pyrophosphonate in pyridine is stable for several months at room temperature.
3. Monitor reactions for disappearance of the starting nucleoside and the formation of
a baseline material by TLC (APPENDIX 3D) on silica-gel plates using 9:1 chloro-
form/methanol as the solvent.
Figure 2.6.2 Synthesis of nucleoside 3′-H-phosphonates using H-pyrophosphonate.
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4. When the reaction is complete (as determined by TLC analysis), add 2 mL of 1 M
TEAB and partition reaction mixture between 75 mL dichloromethane and 50 mL of
2 M TEAB.
5. Separate the organic layer, dry it over ~10 g sodium sulfate, and evaporate solvent
under reduced pressure using a rotary evaporator connected to a water aspirator.
6. Purify crude product by short-column silica-gel chromatography (APPENDIX 3E) on a
4 × 25–cm glass chromatography column using a stepwise gradient of methanol in
chloroform to elute products.
For example, a stepwise gradient of 0% to 12% methanol in chloroform containing 0.1%
triethylamine can be used.
Unwanted isomers of the ribonucleoside H-phosphonates, that is 3′-TBDMS (or 2-ClBz)
2′-H-phosphonates, if present, are readily removed by silica-gel chromatography.
7. Check eluate fractions for H-phosphonate purity by TLC using 0.5:1:8.5 or 1:2:7
(v/v/v) concentrated ammonia/water/isopropanol as the solvents.
The polarity, and thus the mobility on TLC, of an H-phosphonate will be affected by its
protecting group. The latter solvent is probably better for more polar compounds.
For compounds bearing more base-labile N-protection, the use of 3:7 or 2:8 (v/v) iso-
propanol/1M TEAB can be advantageous.
8. Combine fractions containing the desired product and concentrate them to a white
foam using the rotary evaporator. Store at <4°C.
A yield of 85% to 95% 3′-H-phosphonate monoesters (triethylammonium salts), based on
the starting quantity of nucleoside, is expected.
Occasionally, DBUH+ salts of H-phosphonate monoesters can be preferred to TEAH+ salts.
The transformation can be effected by washing a solution of nucleoside H-phosphonate
monoester (triethylammonium salt) in dichloromethane with 0.2 M 1,8-diazabicy-
clo[5.4.0]undec-7-ene (DBU) bicarbonate buffer (pH 8.5).
When NEPCl is used to generate H-pyrophosphonate from phosphorous acid, the isolated
nucleoside H-phosphonate monoesters can be occasionally contaminated by hydrolysis
products of the condensing agent. If this is the case (as shown by 31P NMR), the product
should be dissolved in 20 mL dichloromethane and washed twice with 5 mL of  0.05 M
TEAB buffer.
9. Optional: Dissolve the foam in a small amount of dichloromethane and add it
dropwise while stirring vigorously to 100 to 150 mL of 1:1 hexane/diethyl ether per
mmol product. Store at <4°C.
The nucleoside H-phosphonate is stored as a microcrystalline solid. Although stable for
several months at room temperature, it should be stored in the freezer to prevent decom-
position due to residual solvents. Under such conditions, no decomposition is seen even
after several months.
BASIC     
PROTOCOL 3
SYNTHESIS OF PROTECTED NUCLEOSIDE 3′-H-PHOSPHONATES USING
DIPHENYL H-PHOSPHONATE
This is a general-purpose procedure, applicable to both ribo- and deoxyribonucleosides.
One should exercise some caution when base-sensitive protecting groups are present in
the substrates (see Commentary). This reaction is shown in Figure 2.6.3.
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Materials
Protected deoxyribo- or ribonucleoside (see Chapter 2), dried by repeated
evaporation of added pyridine
Pyridine (HPLC grade; e.g., Labscan), dried by and stored over 4A molecular
sieves
Diphenyl H-phosphonate, commercial grade (e.g., Aldrich)
9:1 (v/v) chloroform/methanol
Triethylamine, distilled, stored over calcium hydride
5% (w/v) sodium bicarbonate
Dichloromethane, distilled
Sodium sulfate
4 × 25–cm glass chromatography column, packed with Merck silica gel 60, 230 to
400 mesh ASTM (e.g., EM Science) or Matrix chloroform (bed height, 10 to 15 cm)
Methanol
Chloroform
0.5:1:8.5 or 1:2:7 (v/v/v) concentrated ammonia/water/isopropanol
1:1 (v/v) hexane/diethyl ether
TLC silica-gel plates (e.g., Merck silica gel 60 F254, EM Science)
Rotary evaporator connected to water aspirator
Additional reagents and equipment for TLC (APPENDIX 3D) and column
chromatography (APPENDIX 3E)
1. Add a protected deoxyribo- or ribonucleoside (1 mmol) to 5 mL pyridine and stir.
Add 1.34 mL diphenyl H-phosphonate (7 mmol) in one portion. Stir ∼15 min.
An excess of phosphonylating agents is necessary to avoid the formation of symmetrical
dinucleoside H-phosphonate diesters.
Diphenyl H-phosphonate may be listed by some suppliers as diphenyl phosphite.
In the instance of 2′-O-protected ribonucleosides, the amount of diphenyl H-phosphonate
can be reduced to 3 mol eq.
2. Monitor reactions for disappearance of the starting nucleoside and the formation of
a baseline material by TLC (APPENDIX 3D) on silica-gel plates using 9:1 chloro-
form/methanol as the solvent.
3. When the reaction is complete (as determined by TLC analysis), add 1 mL water and
1 mL triethylamine to quench the reaction, and let mixture stand 15 min.
Figure 2.6.3 Synthesis of nucleoside 3′-H-phosphonates using diphenyl H-phosphonate.
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4. Use a rotary evaporator connected to a water aspirator to evaporate solvents, and
partition the residue between 20 mL dichloromethane and 20 mL of 5% sodium
bicarbonate.
5. Extract organic phase twice with 20 mL of 5% sodium bicarbonate, dry it over ~10 g
sodium sulfate, and evaporate the solvent to produce an oil.
Most phenol and phenyl H-phosphonates formed during the reaction and from hydrolysis
of diphenyl H-phosphonate are removed by the aqueous sodium bicarbonate extraction.
Crude reaction products (after extraction with aqueous sodium bicarbonate) can be
precipitated from dichloromethane into 1:1 (v/v) hexane/diethyl ether to produce nucleo-
side H-phosphonates of >95% purity, without chromatography.
6. Purify crude product by short-column silica-gel chromatography (APPENDIX 3E) on a
4 × 25–cm glass chromatography column using a stepwise gradient of  methanol in
chloroform to elute products.
For example, a stepwise gradient of 0% to 12% methanol in chloroform containing 0.1%
triethylamine can be used.
Unwanted isomers of the ribonucleoside H-phosphonates, that is 3′-TBDMS (or 2-ClBz)
2′-H-phosphonates, if present, are readily removed by silica-gel chromatography.
7. Check eluate fractions for H-phosphonate purity by TLC using 0.5:1:8.5 or 1:2:7
concentrated ammonia/water/isopropanol.
The polarity, and thus the mobility on TLC, of an H-phosphonate will be affected by its
protecting group. The latter solvent is probably better for more polar compounds.
For compounds bearing more base-labile N-protection, the use of 3:7 or 2:8 (v/v) iso-
propanol/1M TEAB can be advantageous.
8. Combine fractions containing the desired product and concentrate them in the rotary
evaporator to a white foam. Store at <4°C.
A yield of 75% to 90% 3′-H-phosphonate monoesters (triethylammonium salts), based on
the starting quantity of nucleoside, is expected.
9. Optional: Dissolve the foam in a small amount of dichloromethane and add it
dropwise while stirring vigorously to 100 to 150 mL of 1:1 hexane/diethyl ether per
mmol product. Store at <4°C.
The nucleoside H-phosphonate is stored as a microcrystalline solid. Although stable for
several months at room temperature, it should be stored in the freezer to prevent decom-
position due to residual solvents. Under such conditions, no decomposition is seen even
after several months.
     BASIC     
PROTOCOL 4
SYNTHESIS OF PROTECTED NUCLEOSIDE 3′-H-PHOSPHONATES USING
2-CHLORO-4H-1,3,2-BENZO-DIOXAPHOSPHINAN-4-ONE
This is a general-purpose protocol applicable to both ribo- and deoxyribonucleotides. This
reaction is shown in Figure 2.6.4.
Materials
Protected deoxyribo- or ribonucleoside (see Chapter 2), dried by repeated
evaporation of added pyridine
2:1 (v/v) dichloromethane/pyridine
1.25 M 2-chloro-4H-1,3,2-benzo-dioxaphosphinan-4-one solution (see recipe)
9:1 (v/v) chloroform/methanol
1 M TEAB, pH 7.5 (see recipe)
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Dichloromethane (99%; HPLC grade), stored over 3A molecular sieves
Sodium sulfate
5 × 25–cm glass chromatography column, packed with Merck silica gel 60, 230 to
400 mesh ASTM (e.g., EM Science) or Matrix silica, 35 to 70 µm (Millipore) in
chloroform (bed height, 10 to 15 cm)
Methanol
Chloroform
0.5:1:8.5 or 1:2:7 (v/v/v) concentrated ammonia/water/isopropanol
1:1 (v/v) hexane/diethyl ether
TLC silica-gel plates (e.g., Merck silica gel 60 F254, EM Science)
Rotary evaporator connected to water aspirator
Additional reagents and equipment for TLC (APPENDIX 3D) and column
chromatography (APPENDIX 3E)
1. Dissolve a protected deoxyribo- or ribonucleoside (1 mmol) in 20 mL of 2:1
dichloromethane/pyridine while stirring and cool solution with an ice/water bath.
2. Add 1 mL of 1.25 M 2-chloro-4H-1,3,2-benzo-dioxaphosphinan-4-one solution in
one portion, while stirring. Remove from bath and stir 15 min.
3. Monitor reactions for disappearance of the starting nucleoside and the formation of
a baseline material by TLC (APPENDIX 3D) on silica-gel plates using 9:1 chloro-
form/methanol as the solvent.
4. When the reaction is complete (as determined by TLC analysis), add 100 mL of 1 M
TEAB to quench reaction and extract the aqueous phase three times with 50 mL
dichloromethane. Collect and pool organic phases.
5. Dry organic phase over ~10 g sodium sulfate, and evaporate solvent under reduced
pressure using a rotary evaporator connected to a water aspirator.
6. Purify crude product by short-column silica-gel chromatography (APPENDIX 3E) on a
5 × 25–cm glass chromatography column using a stepwise gradient of methanol in
chloroform to elute products.
For example, a stepwise gradient of 0% to 12% methanol in chloroform containing 0.1%
triethylamine can be used.
Figure 2.6.4 Synthesis of nucleoside 3′-H-phosphonates using salicylchlorophosphite.
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Unwanted isomers of the ribonucleoside H-phosphonates, that is 3′-TBDMS (or 2-ClBz)
2′-H-phosphonates, if present, are readily removed by silica-gel chromatography.
7. Check eluate fractions for H-phosphonate purity by TLC using 0.5:1:8.5 or 1:2:7
concentrated ammonia/water/isopropanol as the solvents.
The polarity, and thus the mobility on TLC, of an H-phosphonate will be affected by its
protecting group. The latter solvent is probably better for more polar compounds.
For compounds bearing more base-labile N-protection, the use of 3:7 or 2:8 (v/v) iso-
propanol/1M TEAB can be advantageous.
With nucleoside H-phosphonate monoesters produced in this way, it can sometimes be
troublesome to remove contaminants resulting from the decomposition products of the
phosphonylating reagent (these are visible as fluorescent spots on TLC plates under a UV
lamp). In such cases, the samples should be rechromatographed.
8. Combine fractions containing the desired product and concentrate them in the rotary
evaporator to a white foam. Store at <4°C.
A yield of 80% to 90% 3′-H-phosphonate monoesters (triethylammonium salts), based on
the starting quantity of nucleoside, is expected.
Occasionally, DBUH+ salts of H-phosphonate monoesters can be preferred to TEAH+ salts.
The transformation can be effected by washing a solution of nucleoside H-phosphonate
monoester (triethylammonium salt) in dichloromethane with 0.2 M 1,8-diazabicy-
clo[5.4.0]undec-7-ene (DBU) bicarbonate buffer (pH 8.5).
9. Optional: Dissolve the foam in a small amount of dichloromethane and add it
dropwise while stirring vigorously to 100 to 150 mL of 1:1 hexane/diethyl ether per
mmol product. Store at <4°C.
The nucleoside H-phosphonate is stored as a microcrystalline solid. Although stable for
several months at room temperature, it should be stored in the freezer to prevent decom-
position due to residual solvents. Under such conditions, no decomposition is seen even
after several months.
REAGENTS AND SOLUTIONS
Use deionized, distilled water in all recipes and protocol steps. For common stock solutions, see
APPENDIX 2A; for suppliers, see SUPPLIERS APPENDIX.
2-Chloro-4H-1,3,2-benzo-dioxaphosphinan-4-one solution, 1.25 M
Prepare crystalline 2-chloro-4H-1,3,2-benzo-dioxaphosphinan-4-one (salicylchlo-
rophosphite) as described (Young, 1952) or purchase commercially (e.g., Aldrich).
Dissolve 2.52 g in 6 mL dioxane and adjust final volume to 10 mL. Prepare fresh.
Store crystalline  product several months at 4°C.
Salicylchlorophosphite was previously called 2-chloro-4H-1,3,2-benzodioxaphosphorin-4-
one and may still be listed as such by some suppliers.
5,5-Dimethyl-2-oxo-2-chloro-1,3,2-dioxaphosphinane (NEPCl)
Prepare this crystalline reagent as described (McConnell and Coover, 1959). Store
several months at room temperature.
Phosphorous acid (H3PO3) solution, 2 M
Evaporate 1.62 g H3PO3 (commercial grade, e.g., Aldrich) from dry pyridine (HPLC
grade, dried and stored over 4A molecular sieves) and dissolve residue in 8 mL dry
pyridine. Adjust final volume to 10 mL. Stored several months at room temperature.
Phosphorous acid in pyridine is prepared according to Stawinski and Thelin (1990a).
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Triethylammonium bicarbonate (TEAB), 2 M, pH 7.5
Bubble CO2 through a suspension of 280 mL triethylamine (2 mol) in 700 mL water
until the pH of the solution reaches 7.5. Adjust final volume to 1 L. Store buffer up
to a few weeks at 4°C and check pH before use. Dilute as needed to appropriate molarity.
COMMENTARY
Background Information
The methods for the preparation of H-phos-
phonate monoesters of natural products can be
divided into four major types. They are based
on: (1) esterification of phosphorous acid in the
presence of various condensing reagents (Hata
and Sekine, 1974; Holy et al., 1965; Schofield
and Todd, 1961; Sekine and Hata, 1975); (2)
reactions of phosphorus trichloride (or reactive
species derived thereof) with alcohols (Holy
and Sorm, 1966; Honjo et al., 1966; Sekine et
al., 1979); (3) transesterification of trialkyl or
triaryl phosphites with appropriate hydroxylic
components (Holy and Smrt, 1966); and (4)
transesterification of β-substituted dialkyl H-
phosphonate diesters with alcohols, followed
by hydrolysis of the produced mixed diesters
(Gibbs and Larsen, 1984; Takaku et al., 1988).
Most of these methods, unfortunately, suffer
from variable yields and are often incompatible
with common protecting groups used in oli-
gonucleotide synthesis.
This unit describes four variants of the above
general types for the preparation of nucleoside
H-phosphonate monoesters: Basic Protocol 2
is a type 1 reaction; Basic Protocol 1, the Al-
ternate Protocol, and Basic Protocol 4 are type
2 reactions; and Basic Protocol 3 is related to
the  type 4 reaction. These methods consis-
tently give high yields of the desired products
(75% to 90%), and taken together they provide
an arsenal of phosphonylation (phosphityla-
tion) procedures that are compatible with most
common protecting groups used in oligode-
oxyribo- and oligoribonucleotide synthesis.
Phosphonylation using phosphorus
trichloride
Phosphonylation of protected nucleosides
using the phosphorus trichloride/imida-
zole/triethylamine reagent system (Basic Pro-
tocol 1) is a mild and efficient method (with
yields of 75% to 90%) for the preparation of
protected deoxyribo- (Garegg et al., 1986a,c)
and r ibonucleoside 3′-H-phosphonates
(Garegg et al., 1986b; Stawinski et al., 1988;
Rozners et al., 1995b, 1998) as well as for
arabinonucleoside H-phosphonates (Rozners
et al., 1995a). A popular variant of this proce-
dure involves the replacement of imidazole by
1,2,4-triazole (Froehler, 1993; Froehler et al.,
1986). Gaffney and Jones (1988) also reported
that using N-methylmorpholine instead of
triethylamine as an acid scavenger offers some
advantages.
Acetonitrile and dichloromethane are com-
monly used as solvents in this procedure. The
phosphonylating reagent is generated in situ
immediately prior to synthesis and the reaction
is frequently carried out in a dry ice/acetone
bath (or a similar bath well below 0°C), which
is particularly beneficial with guanine-contain-
ing nucleosides as these are prone to side reac-
tions. (The side products that can be formed are
readily removed, but they will lower the yields.)
The reagent is probably made less suitable for
a large-scale production of building blocks,
because of the use of a sub-zero cold bath.
A convenient procedure for one-flask 2′-hy-
droxyl protection (2-chlorobenzoylation) and
subsequent phosphonylation using this reagent
(Alternate Protocol) has also been developed
(Rozners et al., 1990, 1992, 1995b, 1998) and
used for the preparation of formacetal-linked
(Rozners and Strömberg, 1997) as well as am-
ide-linked (D. Katkevica, E. Rozners, E.
Bizdena, and R. Strömberg, unpub. observ.)
dimeric H-phosphonate building blocks. An-
other recent procedure for preparation of
purine-containing ribonucleoside building
blocks is based on the reaction of tris(tria-
zolyl)phosphine with 2′,3′-unprotected purine
ribonucleosides to produce, after hydrolysis, an
isomeric mixture of 2′- and 3′-H-phosphonates.
Upon silylation with TBDMS⋅Cl, this mixture
gives a remarkable selectivity of 85% to 90%
for 2′-O-silylation (Zhang et al., 1997).
Phosphonylation using phosphorous acid
esterification
Direct condensation of phosphorous acid
with appropriate alcohols in the presence of an
arene sulfonyl derivative (Sekine and Hata,
1975) to produce H-phosphonate monoesters
is of little synthetic value due to the con-
comitant formation of H-phosphonate di-
esters (Sekine et al., 1988) and oxidation
of H-phosphonate monoesters (Garegg et al.,
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1987). However, by using a limited amount of
a condensing agent such as pivaloyl chlo-
ride or 5,5-dimethyl-2-oxo-2-chloro-1,3,2-
dioxaphosphinane (McConnell and Coover,
1959; Basic Protocol 2), it is possible to convert
phosphorous acid into its H-pyrophosphonate
(Stawinski and Thelin, 1990b), which in turn
may act as a mild phosphonylating agent (Staw-
inski and Thelin, 1990a). The procedure is
experimentally simple and reliable, and pro-
duces deoxyribonucleoside 3′-H-phosphonate
in yields of 86% to 92% (Stawinski and Thelin,
1990a).
Pyridinium H-pyrophosphonate can also be
prepared and stored for several months at room
temperature as a stock solution in pyridine.
Reaction mixtures containing a nucleoside and
5 mol eq of pyrophosphonate can be left over-
night without the danger of side reactions with
heterocyclic base residues because of this re-
agent’s moderate reactivity (Stawinski and
Thelin, 1990a). However, this reagent is rather
slow to react with sterically hindered hydroxyl
functions such as the 3′-hydroxyl group in 2′-
O-TBDMS ribonucleosides (Stawinski and
Thelin, 1990a), and thus cannot be recom-
mended for preparation of ribonucleoside H-
phosphonate building blocks. The mild reac-
tion conditions, experimental simplicity, and
inexpensive starting materials make this
method a strong candidate for large-scale
preparations of deoxyribonucleotide H-phos-
phonates.
Phosphonylation by transesterification
Transesterification of diphenyl H-phos-
phonate with protected nucleosides (Basic Pro-
tocol 3) is a most convenient approach for the
preparation of H-phosphonate building blocks.
Diphenyl H-phosphonate is an inexpensive and
commercially available reagent that is stable
and easy to handle. H-Phosphonate monoesters
are synthesized with a purity usually >95%
even without column chromatography (Jank-
owska et al., 1994). No side reactions involving
the heterocyclic bases were detected. The same
observation has also been reported for nucleo-
sides with unprotected nucleobases (Wada et
al., 1997). Although the reagent in pyridine
undergoes disproportionation (Kers et al.,
1996), this process is much slower than the
transesterification reaction, and the side prod-
ucts formed (phenyl H-phosphonate and
triphenyl phosphite) are easily removed during
subsequent purification steps.
Diphenyl H-phosphonate usually has to be
used in a 3 to 7 mol eq excess of the nucleoside
to minimize the formation of symmetrical H-
phosphonate diesters. However, by introducing
some changes into the protocol (Jankowska et
al., 1994), it is possible to reduce significantly
the excess of diphenyl H-phosphonate. The
method has been used for the preparation of
both deoxyribo- and ribonucleoside H-phos-
phonates. It may, however, pose some problems
when applied to ribonucleosides carrying more
base-labile protection (e.g., N-phenoxyacetyl
protection), due to the relatively basic condi-
tions required for hydrolysis of 2′-O-TBDMS-
protected nucleoside 3′-(phenyl H-phosphon-
ate).
Phosphonylation using
salicylchlorophosphite
Nucleoside H-phosphonate monoesters
are also easily accessible via the salicylchlo-
rophosphite method (Basic Protocol 4),
which utilizes 2-chloro-4H-1,3,2-benzo-di-
oxaphosphinan-4-one as the phosphonylating
reagent (Marugg et al., 1986). Salicylchloro-
phosphite is crystalline, stable, readily pre-
pared (Young, 1952), and also commercially
available. Although the phosphonylation is vir-
tually quantitative, some amounts of the hy-
droxylic component (∼5%) are occasionally
regenerated during hydrolysis of the phosphite
intermediate (Froehler, 1993). The most seri-
ous inconvenience of the method is that it often
can be difficult to separate the nucleoside H-
phosphonate from hydrolysis products of the
phosphonylating reagent.
Some other synthetic methods that have
been used for preparation of nucleoside H-
phosphonate monoesters are: (1) phosphonyla-
tion of nucleosides with 2-cyanoethyl phos-
phordiamidite, hydrolysis to the H-phosphon-
ate diester,  and β-elimination of the
2-cyanoethyl group (Garegg et al., 1985); (2)
phosphonylation of nucleosides with 2-cy-
anoethyl H-phosphonate, followed by β-elimi-
nation (Szabó et al., 1995); (3) condensation of
aryl H-phosphonates with nucleosides, fol-
lowed by hydrolysis (Ozola et al., 1996); (4)
anionic debenzylation of nucleoside benzyl H-
phosphonates (Hall et al., 1957); (5) oxidative
phosphonylation with phosphinic acid in the
presence of mesitylenedisulfonyl chloride
(Sekine et al., 1988); (6) reaction of nucleoside
bis-(N,N-di-isopropylamino)chlorophosphine,
followed by acidolysis (Marugg et al., 1986);
and (7) condensation of phosphorous acid with
nucleosides promoted by triphosgene (Bhongle
and Tang, 1995).
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Critical Parameters
For these protocols, anhydrous reaction con-
ditions must be used, especially if the phos-
phonylating reagent is present in almost
stoichiometric amounts. Solvents should be
stored over molecular sieves (or be freshly
distilled). All glassware should be dried in an
oven prior to use. The air inlets of apparatuses
used in syntheses should be connected to at-
mospheric pressure through a drying tower. All
nucleosides should be anhydrous, which is usu-
ally most conveniently accomplished by re-
peated evaporation of added pyridine.
The purity of the produced compounds
should be checked by NMR spectroscopy (31P
and 1H), but TLC is also most convenient,
especially for the detection of minor amounts
of impurities. For example, the contamination
of ribonucleoside H-phosphonate building
blocks with the 3′-O-protected 2′-H-phosphon-
ate isomers can be conveniently detected by
TLC analysis, as these separate well in ammo-
nia/water/isopropanol systems (and usually
also in isopropanol/TEAB).
In the phosphorus trichloride/imidazole
method, the slow addition of nucleoside (see
Basic Protocol 1, step 3) is important to reduce
the formation of symmetrical H-phosphonate
diesters. It is also important to note that a low
temperature is required to avoid side reactions
on guanine-containing nucleosides. Although
the procedure is rather insensitive to the kind
of azole used, there is a higher risk of formation
of the symmetrical H-phosphonate esters using
triazole (or tetrazole) rather than imidazole due
to the higher reactivity of the former reagents.
Imidazole is also less costly. If overly concen-
trated solutions or too small an excess of re-
agent is used, or if the nucleoside solution is
added too quickly, smaller or larger amounts of
symmetrical H-phosphonate diesters can be
formed. These can be easily hydrolyzed during
subsequent purification (giving monoester
product and nucleoside), but their formation
will lower the yield of the H-phosphonate
monoesters.
For the pyrophosphonate method, pyridine
seems to be an optimal solvent. Strong bases
(e.g., triethylamine) or basic nucleophilic cata-
lysts (e.g., N-methylimidazole) should be
avoided, because they usually slow down the
phosphonylation. When NEPCl is used to gen-
erate H-pyrophosphonate, the resulting H-
phosphonate monoesters should be checked for
impurities arising from the condensing agent
(e.g., by 31P NMR). During the phosphonyla-
tion of nucleosides, two species are formed
from the condensing agent: 5,5-dimethyl-2-
oxo-2-hydroxy-1,3,2-dioxaphosphinane and
its pyrophosphate. The first product is usually
completely removed during the extraction step.
The second product is easy to remove during
chromatography, but may slowly hydrolyze on
silica gel, releasing 5,5-dimethyl-2-oxo-2-hy-
droxy-1,3,2-dioxaphosphinane.
Transesterification of diphenyl H-phos-
phonate also works best when pyridine is used
as solvent and base. The reaction in neutral
solvents in the presence of a strong base (e.g.,
triethylamine) may fail due to rapid dispropor-
tionation of the phosphonylation reagent under
such conditions.
Formation of symmetrical H-phosphonates
is usually not detected when salicylchloro-
phosphite is used as a phosphonylating reagent.
The purity of nucleoside H-phosphonates pre-
pared by this method should be carefully
checked, however, for the presence of fluores-
cent spots visible on TLC plates under UV light.
These are due to contamination by hydrolysis
products of the phosphonylating reagent,
which may be nontrivial to remove by silica-gel
chromatography.
Anticipated Results
All methods described in this unit afford,
after silica-gel column chromatography, nu-
cleoside H-phosphonate monoesters of compa-
rable quality and in comparable yields, but they
vary in their suitability for the preparation of
different nucleoside derivatives. All methods
can be scaled up to ~25-mmol reactions. A
1-mmol scale generates 0.5 to 1 g product and
a 25-mmol scale generates 15 to 25 g. Com-
pounds prepared by any of these methods are
suitable for solid-phase as well as solution
synthesis of oligonucleotides and their analogs.
For deoxyribonucleoside H-phosphonates
bearing quite stable N-acyl protection, all meth-
ods can produce good results. For ribonu-
cleoside H-phosphonates, the pyrophosphon-
ate method seems to be too slow, although it
may be preferred in large-scale preparation of
deoxyribonucleoside building blocks (another
possible choice for this being the diphenyl
H-phosphonate method). For use with ribonu-
cleosides carrying more base-labile N-protec-
tion, the phosphorus trichloride/imidazole
method is still preferred, with the salicylchlo-
rophosphite approach being the second alterna-
tive.
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Time Considerations
None of the procedures described in this unit
are very time consuming. The whole synthesis
procedure including workup usually does not
take more than a few hours. The pyrophosphon-
ate method is the slowest one, but in this in-
stance the reaction mixtures can conveniently
be left overnight. Together with chroma-
tographic purification, it will take from half a
day to a day, depending on method, to obtain
the purified nucleoside H-phosphonates. The
method that probably involves the least manual
effort and technical skill is the diphenyl H-
phosphonate procedure.
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